(AZBJ) AllianzIM U.S. Large Cap - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US00888H8025 • Defined Outcome
AZBJ: Equities, Options, Index Funds
The AllianzIM U.S. Large Cap Buffer20 Jan ETF (NYSE ARCA: AZBJ) is designed to provide exposure to U.S. large-cap equities with a defined outcome strategy. Under normal market conditions, the fund allocates at least 80% of its net assets to financial instruments that mimic the economic characteristics of U.S. large-cap stocks. The Advisor primarily uses FLEX Options tied to the S&P 500 Price Index to achieve this exposure. FLEX Options are customizable contracts that allow the fund to implement its buffering strategy, aiming to limit downside risk while participating in potential upside. The fund is non-diversified, meaning it can concentrate its investments in a smaller number of securities, which may increase risk but also allows for targeted exposure to the S&P 500.
As a Defined Outcome ETF, AZBJ is structured to offer investors a specific risk-return profile. The funds use of FLEX Options enables it to establish a buffer against losses, typically within a predefined range, while capping potential gains. This structure is particularly appealing to investors seeking equity exposure with reduced volatility. The funds assets under management (AUM) of $459.91 million indicate a moderate scale, which can support liquidity and operational efficiency. The average trading volume of 46,092 shares over the past 20 days suggests steady investor activity without excessive turnover.
From a technical perspective, AZBJ is currently trading at $33.94, slightly below its 20-day simple moving average (SMA) of $34.10 but above its 50-day SMA of $33.87 and 200-day SMA of $32.93. This indicates that the fund is in a consolidative phase, with support levels likely forming around the 50-day and 200-day SMAs. The Average True Range (ATR) of 0.16 reflects relatively low volatility, suggesting that price movements are contained within a narrow range.
Over the next three months, AZBJ is expected to trade within a range of $33.50 to $34.50, with potential resistance at the 20-day SMA and support at the 50-day SMA. The low ATR suggests that volatility will remain subdued, and the fund is likely to maintain its current consolidative pattern. The AUM of $459.91 million provides stability, and the funds defined outcome strategy will continue to appeal to risk-averse investors seeking exposure to U.S. large-cap equities with built-in downside protection.
Additional Sources for AZBJ ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
AZBJ ETF Overview
Market Cap in USD | 455m |
Category | Defined Outcome |
TER | 0.74% |
IPO / Inception | 2020-12-31 |
AZBJ ETF Ratings
Growth 5y | 66.6% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -3.4 |
Analysts | - |
Fair Price Momentum | 32.06 USD |
Fair Price DCF | - |
AZBJ Dividends
No Dividends PaidAZBJ Growth Ratios
Growth Correlation 3m | 34.6% |
Growth Correlation 12m | 97% |
Growth Correlation 5y | 87% |
CAGR 5y | 6.92% |
CAGR/Max DD 5y | 0.71 |
Sharpe Ratio 12m | 1.17 |
Alpha | 0.57 |
Beta | 0.29 |
Volatility | 13.32% |
Current Volume | 37.9k |
Average Volume 20d | 39.4k |
As of March 14, 2025, the stock is trading at USD 33.10 with a total of 37,866 shares traded.
Over the past week, the price has changed by -1.01%, over one month by -3.27%, over three months by -1.28% and over the past year by +5.97%.
Yes. Based on ValueRay Analyses, AllianzIM U.S. Large Cap (NYSE ARCA:AZBJ) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 66.61 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AZBJ as of March 2025 is 32.06. This means that AZBJ is currently overvalued and has a potential downside of -3.14%.
AllianzIM U.S. Large Cap has no consensus analysts rating.
According to ValueRays Forecast Model, AZBJ AllianzIM U.S. Large Cap will be worth about 34.8 in March 2026. The stock is currently trading at 33.10. This means that the stock has a potential upside of +5.14%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 34.8 | 5.1% |